NCT04234230

Brief Summary

The number of patients with end-stage heart disease requiring the implantation of ventricular assist devices (VAD) is steadily increasing. Living with a VAD exposes the patients to multiple challenges and the need to learn complex self-management skills. Inadequate self-management can lead to serious complications (e.g. bleeding or wound infections) and impair the psychosocial outcome. This study aims to provide multi-centered actual analysis of self-management capabilities as well as analyzing moderating predictors in VAD patients through standardized prevalence assessment. Using a cross-sectional design, this prevalence study will be conducted at four established German heartcenters (Freiburg, Berlin, Bad Oeynhausen, Leipzig). VAD-patients are questioned about their self-management skills using standardized Patient-reported outcome (PRO) measures. Secondary PRO measures include health-related quality of life, symptoms of anxiety and depression, post-traumatic stress symptoms, social support, and changed body-image. Relevant complications (bleeding, wound infections, thromboembolic neurological events) are taken from the patient records. Based on a conservative sample size estimation inclusion of 450 patients is envisioned. The expected results may contribute to an improved assessment of the current situation in terms of self-management skills and needs for curricular training concepts and psychosocial concomitant therapy. Long-term, the study results contribute to improve the health care for long-term VAD patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
393

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2019

Shorter than P25 for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2019

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

October 2, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 21, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
Last Updated

November 6, 2020

Status Verified

November 1, 2020

Enrollment Period

11 months

First QC Date

October 2, 2019

Last Update Submit

November 5, 2020

Conditions

Keywords

Ventricular Assist DeviceSelf-managementPsychosocial Factors

Outcome Measures

Primary Outcomes (1)

  • Self-management Skills

    As an assessment instrument a standardized PRO measure was chosen to identify self-management skills and needs.

    October 2019 till January 2020

Secondary Outcomes (5)

  • Health-related Quality of Life

    October 2019 till January 2020

  • Social Support

    October 2019 till January 2020

  • Symptoms of Anxiety

    October 2019 till January 2020

  • Symptoms of Depression

    October 2019 till January 2020

  • Symptoms of Posttraumatic Stress Disorder

    October 2019 till January 2020

Other Outcomes (4)

  • Comorbidities

    October 2019 till January 2020

  • VAD Type

    October 2019 till January 2020

  • New York Heart Association (NYHA) classification

    October 2019 till January 2020

  • +1 more other outcomes

Study Arms (1)

VAD Patients

Patients with implanted ventricular assist device in the outpatient setting

Other: Prevalence Survey

Interventions

Questionnaire survey on self-management

VAD Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients implanted with a ventricular assist device in the outpatient setting of four heart centers in Germany (Freiburg, Berlin, Bad Oeynhausen and Leipzig).

You may qualify if:

  • Outpatient at the respective heart center
  • Living in a home environment
  • On device between 3 months and 3 years
  • years and older
  • No contraindications (e.g. cognitive, language)
  • Signed Informed Consent

You may not qualify if:

  • In-patient stay
  • Not living in a home environment (e.g. assisted living)
  • On device less than 3 months or more than 3 years
  • Underage
  • Contraindications (e.g. cognitive, language)
  • No signed Informed Consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

University Heart Center Freiburg

Freiburg im Breisgau, Baden-Wurttemberg, 79110, Germany

Location

Heart and Diabetes Center North Rhine-Westphalia

Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany

Location

Leipzig Heart Center

Leipzig, Saxony, 04289, Germany

Location

German Heart Center

Berlin, 13353, Germany

Location

Related Publications (5)

  • Kugler C, Spielmann H, Albert W, Lauenroth V, Spitz-Koeberich C, Semmig-Koenze S, Staus P, Tigges-Limmer K; SELMA Study Group. Professional Employment in Patients on Ventricular Assist Device Support-A National Multicenter Survey Study. ASAIO J. 2024 May 1;70(5):348-355. doi: 10.1097/MAT.0000000000002124. Epub 2024 Jan 3.

  • Spielmann H, Tigges-Limmer K, Albert W, Spitz-Koberich C, Semmig-Konze S, Staus P, Herrmann-Lingen C, Sandau KE, Okeson B, Geyer S, Kugler C; Selma Study Group. Health-Related Quality of Life in Patients With Ventricular Assist Device: Psychometric Evaluation of the German Version of the Quality of Life With a Ventricular Assist Device Questionnaire. J Cardiovasc Nurs. 2024 Nov-Dec 01;39(6):571-582. doi: 10.1097/JCN.0000000000001064. Epub 2023 Nov 22.

  • Spielmann H, Albert W, Semmig-Konze S, Lauenroth V, Spitz-Koberich C, Staus P, Tigges-Limmer K, Kugler C; SELMA Study Group. High level of psychosocial adjustment in patients on ongoing ventricular assist device support in the years one to three after VAD implantation-A national multi-center Study. Heart Lung. 2024 Jan-Feb;63:92-97. doi: 10.1016/j.hrtlng.2023.10.003. Epub 2023 Oct 12.

  • Kugler C, Spielmann H, Seemann M, Lauenroth V, Wacker R, Albert W, Spitz-Koeberich C, Semmig-Koenze S, von Cube M, Tigges-Limmer K. Self-management for patients on ventricular assist device support: a national, multicentre study: protocol for a 3-phase study. BMJ Open. 2021 May 5;11(5):e044374. doi: 10.1136/bmjopen-2020-044374.

  • Spielmann H, Seemann M, Friedrich N, Tigges-Limmer K, Albert W, Semmig-Konze S, Spitz-Koberich C, Kugler C. Self-management with the therapeutic regimen in patients with ventricular assist device (VAD) support - a scoping review. Heart Lung. 2021 May-Jun;50(3):388-396. doi: 10.1016/j.hrtlng.2021.01.019. Epub 2021 Feb 20.

MeSH Terms

Interventions

Contraceptive Prevalence Surveys

Intervention Hierarchy (Ancestors)

Surveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Christiane Kugler, Prof. Dr.

    University of Freiburg

    STUDY DIRECTOR
  • Christiane Kugler, Prof. Dr.

    University of Freiburg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Doctor. rer. biol. hum.

Study Record Dates

First Submitted

October 2, 2019

First Posted

January 21, 2020

Study Start

October 1, 2019

Primary Completion

August 31, 2020

Study Completion

September 30, 2020

Last Updated

November 6, 2020

Record last verified: 2020-11

Locations